Weight Loss Drugs Explained: Options
Weight loss drugs compared: how GLP-1s and older prescriptions work, side effects, costs, and who they help. Make an informed choice with your doctor.

Save articles to read later and create your own reading list.

Weight loss drugs compared: how GLP-1s and older prescriptions work, side effects, costs, and who they help. Make an informed choice with your doctor.
- GLP-1 drugs like semaglutide and tirzepatide produce the largest average weight losses in clinical trials, often around 15-20% of body weight.
- Older prescription weight loss drugs are cheaper but typically deliver more modest results.
- Side effects are common, mostly gastrointestinal, and some people should avoid these medications entirely.
- Cost and insurance coverage remain the biggest practical barriers for most patients.
- Medication works best paired with habit tracking, weigh-ins, and sustainable routines.
- Always decide with your doctor — this article is education, not medical advice.
Frequently asked questions
Tirzepatide (Zepbound) and semaglutide 2.4 mg (Wegovy) produce the largest average weight losses in clinical trials, roughly 15-21% and ~15% of body weight respectively. Individual results vary widely, and both require medical supervision.
Most people notice reduced appetite within the first few weeks, with meaningful weight change typically visible by 8-12 weeks. Full effects in trials were measured at 68 weeks, so patience and consistent dosing matter.
Often, yes. Trials show substantial weight regain after discontinuation, which is why these medications are usually prescribed as long-term therapy combined with lasting habit changes.
No. Effective prescription weight loss drugs require a doctor's evaluation. Over-the-counter orlistat (Alli) is the main non-prescription option, with modest results and gastrointestinal side effects.
Sometimes. Many US plans cover GLP-1s for type 2 diabetes but not obesity alone, though coverage is expanding. Ask your insurer specifically about anti-obesity medication benefits and prior authorization requirements.
People with a personal or family history of medullary thyroid carcinoma or MEN2, those who are pregnant or breastfeeding, and those with certain pancreatic or severe gastrointestinal conditions should avoid them. Your doctor will screen for these.
Yes. Donations made directly to GoWithFund Inc. (a registered 501(c)(3) public charity in Idaho, EIN: 33-1243835) or to its verified fiscally sponsored projects are tax-deductible to the fullest extent permitted under IRC Section 170. Donors automatically receive official IRS substantiation receipts via email.
Direct 501(c)(3) incorporation requires forming a nonprofit corporation, drafting bylaws, recruiting an independent board of directors, paying IRS Form 1023 filing fees ($275 or $600), and waiting 3 to 12 months for IRS determination. Comprehensive fiscal sponsorship allows mission-driven projects to launch immediately under an established charity's legal umbrella with zero corporate overhead.
Organizations with gross annual receipts normally <= $50,000 file the electronic Form 990-N (e-Postcard). Organizations with gross receipts < $200,000 and total assets < $500,000 may file Form 990-EZ. Organizations exceeding those thresholds must file full Form 990 annually by the 15th day of the 5th month after their fiscal year closes.
Payments processed through third-party payment settlement entities (like Stripe) may generate a Form 1099-K if gross transaction volumes exceed prevailing IRS or state reporting thresholds. However, bona fide personal charitable gifts and tax-exempt contributions are generally not considered gross taxable income.
Under IRC Section 170(f)(8), donors must obtain a contemporaneous written acknowledgment (CWA) from the recipient charity before filing their federal tax return. GoWithFund automatically issues receipts containing the organization's EIN, donation amount, date, and a statement confirming no goods or services were provided in return.
A for-profit entity cannot be fiscally sponsored for general corporate operations. However, specific charitable, educational, or scientific programs operated by social enterprises can receive grant funding under Comprehensive Model A or Pre-Approved Grant Relationship Model C fiscal sponsorships provided all funds are restricted strictly to 501(c)(3) exempt activities.
GoWithFund charges a 0% platform fee on all charitable campaigns and donations. 100% of the net contribution directly supports the initiative, with only standard third-party Stripe payment processing fees (2.9% + $0.30 per transaction) applying, which donors can voluntarily choose to cover at checkout.
Verified campaign organizers receive automated direct bank payouts via Stripe Connect within 1 to 2 business days after statutory verification, eliminating weeks of manual check clearing or intermediary administrative delays.

GoWithFund Editorial Team
Staff Contributor
Published on behalf of GoWithFund Inc., a registered U.S. 501(c)(3) tax-exempt public charity in Idaho (EIN: 33-1243835 | Idaho SOS #5902503). Articles are reviewed for statutory compliance under IRS Internal Revenue Code Section 170.
Related Topics
Put these Weight Loss solutions into practice
Launch your initiative, access verified tools, and streamline your operations with 0% platform fee infrastructure.
Related Articles

Weight Loss for Prediabetes: A Food-First Plan
Made simple: glucose-friendly meals, habit tracking, and sustainable steps to lower blood sugar and lose weight safely.

GoWithFund Editorial Team
Staff Contributor

Weight Loss Web App: Advanced Implementation Playbook (2026)
Sustainable metabolic habit tracking: smoothed moving-average weigh-ins, macro adherence, and lifestyle protocols for weight loss web app guide cqhw.
GoWithFund Support
Director, GoWithFund Inc.

Adaptive Thermogenesis Explained Simply
Learn why progress stalls, how energy expenditure shifts, and when to adjust calories or take a diet break.

GoWithFund Editorial Team
Staff Contributor
